# Modern UV filters vs legacy filters Source: https://theconstantbeauty.com/compare/modern-uv-filters-vs-legacy-filters/ Retrieved for: theconstantbeauty.com Publisher: The Constant (theconstantbeauty.com). Cite as "The Constant". Generated: 2026-09-16T18:22Z **Compares:** Modern filters (Tinosorb S, Tinosorb M, Uvinul A Plus) vs Legacy filters (avobenzone, oxybenzone, octinoxate) **Criteria:** Spectrum covered, Photostability, Skin absorption, Sensory and texture, EU limits (Annex VI), US and India status (to our understanding), Environmental notes ## Context for the verdict Choose a modern-filter sunscreen if you want deep UVA1 protection in a comfortable texture, if you are outdoors for hours and need protection that lasts, if your skin has reacted to oxybenzone, or if you prefer filters with very low measured skin absorption. In India these are readily available. Choose a legacy-filter sunscreen if you need a product that complies with the US monograph or if cost is the deciding factor. Look for avobenzone paired with a stabiliser, and avoid products that combine it with octinoxate. Whichever you pick, the dose matters more than the filter list. Two finger-lengths for the face and neck, reapplied every two to three hours outdoors, is what the SPF number assumes. ## Comparison Sunscreen filters fall into two generations. The legacy organic filters, avobenzone, oxybenzone and octinoxate, were approved in the United States decades ago. The newer filters, bemotrizinol (Tinosorb S), bisoctrizole (Tinosorb M) and diethylamino hydroxybenzoyl hexyl benzoate (Uvinul A Plus), came out of Europe from the late 1990s. They are permitted in the EU, Australia, Japan and, to our understanding, India, but had not been approved in the US as of our last review. The differences are physical. Avobenzone, the main legacy UVA filter, is not photostable on its own: it loses a meaningful share of its absorbance in sunlight unless stabilised, and octinoxate accelerates that breakdown. Oxybenzone covers UVB and short UVA but is one of the more frequent photoallergens among filters, and in FDA-run maximal-use trials published in JAMA in 2019 and 2020 it was measured in blood well above the agency’s 0.5 ng/mL safety-testing threshold. Oxybenzone and octinoxate have also been banned from sale in Hawaii since 2021 over coral reef concerns. The modern filters were designed around those problems. All three are photostable. Tinosorb S and Tinosorb M cover UVB through UVA1 in a single molecule; Uvinul A Plus is a stable, dedicated UVA1 filter peaking around 354 nm. Tinosorb S and M are large molecules, over 600 daltons, and measured skin penetration for all three is very low. Tinosorb M, a micro-fine particle dispersion, also scatters and reflects, which helps efficiency but can leave a faint cast at high levels. Efficient, stable filters reach SPF 50+ and PA++++ with a lower total load, which is usually why a modern-filter sunscreen feels lighter. Regulation shapes availability. The EU permits each modern filter at up to 10% and lowered the oxybenzone limit in 2022. The US approves the legacy three under its monograph and none of the modern three. India’s list of permitted UV filters broadly follows the EU annex, so both generations are sold here. The table carries the figures as we understand them; rules change, so check current annexes before relying on them. ## References 1. Matta MK, Zusterzeel R, Pilli NR, et al. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA. 2019;321(21):2082–2091. 2. Matta MK, Florian J, Zusterzeel R, et al. Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA. 2020;323(3):256–267. 3. Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products, Annex VI: list of UV filters allowed in cosmetic products (as amended). 4. State of Hawaii, Act 104 (Senate Bill 2571, 2018): prohibition on the sale of sunscreens containing oxybenzone or octinoxate, effective 1 January 2021.